Intranasal Oxytocin: Investigational Social-Cognition Peptide
Intranasal formulation of oxytocin studied for autism, social anxiety, bonding and other psychiatric indications. Intravenous oxytocin is approved for labour but intranasal is investigational.
👥 Human studies
- Full name
- Oxytocin (intranasal)
- Class
- Nine-residue peptide hormone
- Half-life
- ~3–5 minutes (plasma); central effects longer
- Route
- Intranasal (research); IV Syntocinon approved for obstetric use
- Developer
- Academic / research; approved IV product: Syntocinon (Novartis)
- Regulatory status
- IV formulation approved for labour; intranasal off-label/research
What it is
Oxytocin is a 9-residue cyclic neuropeptide from the posterior pituitary. Beyond obstetric effects (uterine contraction, lactation), central oxytocin modulates social cognition, trust, and affiliation — the basis for intranasal research.
How it works
Peripheral oxytocin does not cross the blood-brain barrier well. Intranasal administration is thought to reach the CNS via olfactory and trigeminal pathways, achieving brain concentrations sufficient for behavioural effects.
Receptor action via the oxytocin receptor modulates amygdala reactivity, social salience, and reward processing. Effects depend heavily on context, individual differences, and relationship to the social stimulus.
What the research shows
Hundreds of small trials; large pivotal trials in autism returned mixed results.
Sikich L. et al. (2021) — SOARS-B autism Phase 3
Sikich L. et al., N Engl J Med 2021;385:1462–1473. 👥 Human studies
290 children with autism received intranasal oxytocin or placebo for 24 weeks.
No significant improvement on the primary social-cognition endpoint; safety was unremarkable.
Limitations: Large negative trial substantially dampened enthusiasm for autism indication.
Kosfeld M. et al. (2005) — trust game
Kosfeld M. et al., Nature 2005;435:673–676. 👥 Human studies
Single-dose intranasal oxytocin increased trusting behaviour in an economic game.
Catalysed a wave of social neuroscience research but replication has been mixed.
Limitations: Small; behavioural economics; reproducibility concerns.
Safety and limitations
Intranasal oxytocin is generally well tolerated: mild headache, nasal irritation, occasional diuresis. Cardiovascular or uterine effects are not seen at research doses.
Clinical effectiveness varies widely and may be context-specific. The SOARS-B negative trial tempered expectations for autism indications.